{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:01:59Z","timestamp":1782975719291,"version":"3.54.5"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Over the last decade, the prevalence of IgE-mediated food allergies has increased, alongside therapeutic innovations such as oral immunotherapy (OIT), omalizumab, combination approaches, intranasal epinephrine, and emerging biomarker-guided strategies. This mini review synthesizes evidence published between 2019 and 2025 and evaluates how these advances intersect with persistent safety and clinical decision-making challenges. Although these therapies demonstrate promising efficacy, validated risk-stratification tools capable of guiding individual treatment selection are lacking. The proposed conceptual framework illustrates how patient characteristics, biomarkers, and treatment-specific risks may ultimately support individualized therapeutic decision-making.<\/jats:p>","DOI":"10.3389\/falgy.2026.1848808","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:34:17Z","timestamp":1782970457000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging innovation and risk: the missing role of validated risk-stratification in IgE-mediated food allergy management"],"prefix":"10.3389","volume":"7","author":[{"given":"Heather M.","family":"Opseth","sequence":"first","affiliation":[{"name":"Doctor of Medical Science Department, Shenandoah University , , VA","place":["Winchester, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Gruver","sequence":"additional","affiliation":[{"name":"Doctor of Medical Science Department, Shenandoah University , , VA","place":["Winchester, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11882-020-0898-7","article-title":"Epidemiology and burden of food allergy","volume":"20","author":"Warren","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/all.16345","article-title":"EAACI Guidelines on the management of IgE-mediated food allergy","volume":"80","author":"Santos","year":"2025","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/ph18030437","article-title":"Omalizumab and oral immunotherapy in IgE-mediated food allergy in children: a systematic review and a meta-analysis","volume":"18","author":"Buono","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.anai.2024.07.034","article-title":"Food allergy yardstick: where does omalizumab fit?","volume":"134","author":"Anagnostou","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.cppeds.2025.101732","article-title":"Emerging therapeutics in the management of food allergy","volume":"55","author":"Hamideh","year":"2025","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/all.15318","article-title":"Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis","volume":"77","author":"Turner","year":"2022","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cea.14241","article-title":"Management of IgE-mediated food allergy in the 21st century","volume":"53","author":"Cafarotti","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-021-00994-0","article-title":"Emerging therapies in anaphylaxis: alternatives to intramuscular administration of epinephrine","volume":"21","author":"Boswell","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/pharmaceutics16060811","article-title":"Development of neffy, an epinephrine nasal spray, for severe allergic reactions","volume":"16","author":"Ellis","year":"2024","journal-title":"Pharmaceutics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.waojou.2025.101069","article-title":"Biologics in IgE-mediated food allergy: a systematic review and meta-analysis of interventional studies","volume":"18","author":"Nurmatov","year":"2025","journal-title":"World Allergy Organ J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/all.16046","article-title":"A randomized, double-blind placebo-controlled study on the efficacy of omalizumab on food allergy threshold in children with severe food allergy","volume":"79","author":"Mortz","year":"2024","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.anai.2024.09.020","article-title":"Community and academic allergists' perspectives on integrating biologics into food allergy care: a qualitative study","volume":"134","author":"Fisher","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-025-00948-5","article-title":"Food oral immunotherapy","volume":"20","author":"McHenry","year":"2025","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.alit.2024.08.002","article-title":"Current perspective on allergen immunotherapy for food allergies","volume":"73","author":"Sato","year":"2024","journal-title":"Allergol Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/pai.13389","article-title":"Biomarkers of diagnosis and resolution of food allergy","volume":"32","author":"Foong","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jaci.2007.01.038","article-title":"The predictive relationship of food-specific serum IgE concentrations to challenge outcomes for egg and milk varies by patient age","volume":"119","author":"Komata","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/all.15217","article-title":"Phase 2, randomized multi oral immunotherapy with omalizumab \u2018real-life' Study","volume":"77","author":"Sindher","year":"2022","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/all.16332","article-title":"Development and acceptability of a decision-aid for food allergy oral immunotherapy in children","author":"Anagnostou","year":"2024","journal-title":"Allergy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/all.16321","article-title":"An algorithm for the diagnosis and management of IgE-mediated food allergy, 2024 update","volume":"80","author":"Santos","year":"2024","journal-title":"Allergy"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1848808\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:34:17Z","timestamp":1782970457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1848808\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":19,"alternative-id":["10.3389\/falgy.2026.1848808"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1848808","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1848808"}}